Status:
COMPLETED
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
Lead Sponsor:
Allergan
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the efficacy and safety of two non-preserved artificial tears, (carboxymethylcellulose 0.5%, + glycerin 0.9% vs. sodium hyaluronate 0.18%) eye drops for the treatment of the signs and sympt...
Eligibility Criteria
Inclusion
- Current use of an artificial tear product at least 2 times per day (e.g. for relief of dry eye symptoms of dryness).
- Be likely to complete the entire course of study and to comply with appropriate instructions
Exclusion
- Have undergone refractive surgery (e.g., cataract surgery, PRK, LASIK, or any surgery involving a limbal or corneal incision) within the last 12 months.
- Have uncontrolled systemic disease
- Are currently using, or have used within 14 days of study enrollment, any ocular medications other than artificial tears
- Have anticipated contact lens wear during the study
- Have an active ocular infection
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00938704
Start Date
June 1 2009
End Date
June 1 2009
Last Update
October 31 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ulm, Germany